RT Journal Article
SR Electronic
T1 Transmission networks of SARS-CoV-2 in coastal Kenya during the first two waves: a retrospective genomic study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.01.21259583
DO 10.1101/2021.07.01.21259583
A1 Agoti, Charles N.
A1 Ochola-Oyier, Lynette Isabella
A1 Mohammed, Khadija Said
A1 Lambisia, Arnold W.
A1 de Laurent, Zaydah R.
A1 Morobe, John M.
A1 Mburu, Maureen W.
A1 Omuoyo, Donwilliams O.
A1 Ongera, Edidah M.
A1 Ndwiga, Leonard
A1 Maitha, Eric
A1 Kitole, Benson
A1 Suleiman, Thani
A1 Mwakinangu, Mohamed
A1 Nyambu, John
A1 Otieno, John
A1 Salim, Barke
A1 Musyoki, Jennifer
A1 Murunga, Nickson
A1 Otieno, Edward
A1 Kiiru, John
A1 Kasera, Kadondi
A1 Amoth, Patrick
A1 Mwangangi, Mercy
A1 Aman, Rashid
A1 Kinyanjui, Samson
A1 Warimwe, George
A1 Phan, My
A1 Agweyu, Ambrose
A1 Cotten, Matthew
A1 Barasa, Edwine
A1 Tsofa, Benjamin
A1 Nokes, D. James
A1 Bejon, Philip
A1 Githinji, George
YR 2021
UL http://medrxiv.org/content/early/2021/11/15/2021.07.01.21259583.abstract
AB Background The transmission networks of SARS-CoV-2 in sub-Saharan Africa remain poorly understood.Methods We undertook phylogenetic analysis of 747 SARS-CoV-2 positive samples collected across six counties in coastal Kenya during the first two waves (March 2020 - February 2021). Viral imports and exports from the region were inferred using ancestral state reconstruction (ASR) approach.Results The genomes were classified into 35 Pango lineages, six of which accounted for 79% of the sequenced infections: B.1 (49%), B.1.535 (11%), B.1.530 (6%), B.1.549 (4%), B.1.333 (4%) and B.1.1 (4%). Four identified lineages were Kenya specific. In a contemporaneous global subsample, 990 lineages were documented, 261 for Africa and 97 for Eastern Africa. ASR analysis identified >300 virus location transition events during the period, these comprising: 69 viral imports into Coastal Kenya; 93 viral exports from coastal Kenya; and 191 inter-county import/export events. Most international viral imports (58%) and exports (92%) occurred through Mombasa City, a key touristic and commercial Coastal Kenya center; and many occurred prior to June 2020, when stringent local COVID-19 restriction measures were enforced. After this period, local virus transmission dominated, and distinct local phylogenies were seen.Conclusions Our analysis supports moving control strategies from a focus on international travel to local transmission.Funding This work was funded by Wellcome (grant#: 220985) and the National Institute for Health Research (NIHR), project references: 17/63/and 16/136/33 using UK aid from the UK Government to support global health research, The UK Foreign, Commonwealth and Development Office.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/AFunding StatementThis work was supported by the National Institute for Health Research (NIHR) (project references 17/63/82 (PI Prof. James Nokes) and 16/136/33 (PI Prof. Mark Wooolhouse) using UK aid from the UK Government to support global health research, The UK Foreign, Commonwealth and Development Office and Wellcome Trust (grant# 220985). The views expressed in this publication are those of the author (s) and not necessarily those of NIHR, the Department of Health and Social Care, Foreign Commonwealth and Development Office, Wellcome Trust or the UK government. Some members of COVID-19 Testing Team at KWTRP were supported by funding received by Dr Marta Maia (BOHEMIA study funded UNITAID), Dr Francis Ndungu (Senior Fellowship and Research and Innovation Action (RIA) grants from EDCTP) and Prof. Anthony Scott (PCIVS grant from GAVI). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Samples analysed here were collected under the Ministry of Health (MoH) protocols as part of the national response to the COVID-19 pandemic. The whole genome sequencing study protocol was reviewed and approved by the Scientific and Ethics Review Committee (SERU), Kenya Medical Research Institute (KEMRI), Nairobi, Kenya (SERU #4035). Individual patient consent was not required by the committee for the use of these samples for genomic surveillance to inform public health response.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCoastal Kenya genomes have been deposited to both GISAID (Accession numbers: EPI_ISL_1039223-29; EPI_ISL1440075-109, IPI_ISL_457845-931; EPI_ISL_568695-872; EPI_ISL806548-717; EPI_ISL_855494-548; EPI_ISL_968807-9245).